Catalyst Pharmaceutical announces dismissal of stockholder class action lawsuit Catalyst Pharmaceutical announced that on January 3, the previously reported stockholder class action lawsuit that had been filed against Catalyst and certain of its officers and directors was dismissed without prejudice. In the Court's order, the plaintiffs were granted leave to file an amended complaint within 20 days. Catalyst has no information as to whether any such amended complaint is planned by the plaintiffs. If an amended complaint is filed in the case, Catalyst intends to vigorously defend the amended lawsuit.
News For CPRX From The Last 14 Days
Check below for free stories on CPRX the last two weeks.